Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Johnson & Johnson (NYSE: JNJ) closed at $206.92 in the last session, down -0.31% from day before closing price of $207.56. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 5.64 million shares were traded. JNJ stock price reached its highest trading level at $207.455 during the session, while it also had its lowest trading level at $204.645.
Ratios:
We take a closer look at JNJ’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.44. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In the most recent recommendation for this company, Scotiabank on November 13, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $230.
On October 20, 2025, Daiwa Securities Upgraded its rating to Outperform which previously was Neutral but kept the price unchanged to $203. Wells Fargo Upgraded its Equal Weight to Overweight on October 03, 2025, while the target price for the stock was maintained at $212.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when JOHNSON & JOHNSON sold 2,200 shares for $10.06 per share. The transaction valued at 22,132 led to the insider holds 4,047,198 shares of the business.
JOHNSON & JOHNSON sold 500 shares of JNJ for $5,000 on Nov 21 ’25. The 10% Owner now owns 4,049,398 shares after completing the transaction at $10.00 per share. On Nov 12 ’25, another insider, JOHNSON & JOHNSON, who serves as the 10% Owner of the company, sold 1,000 shares for $10.00 each. As a result, the insider received 10,000 and left with 4,049,898 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JNJ now has a Market Capitalization of 498531336192 and an Enterprise Value of 525764329472. As of this moment, Johnson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.97, and their Forward P/E ratio for the next fiscal year is 17.98. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.41 while its Price-to-Book (P/B) ratio in mrq is 6.28. Its current Enterprise Value per Revenue stands at 5.706 whereas that against EBITDA is 16.47.
Stock Price History:
The Beta on a monthly basis for JNJ is 0.34, which has changed by 0.33669245 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, JNJ has reached a high of $207.81, while it has fallen to a 52-week low of $140.68. The 50-Day Moving Average of the stock is 8.50%, while the 200-Day Moving Average is calculated to be 22.36%.
Shares Statistics:
According to the various share statistics, JNJ traded on average about 8.67M shares per day over the past 3-months and 11048940 shares per day over the past 10 days. A total of 2.41B shares are outstanding, with a floating share count of 2.41B. Insiders hold about 0.12% of the company’s shares, while institutions hold 74.43% stake in the company. Shares short for JNJ as of 1763078400 were 20122322 with a Short Ratio of 2.32, compared to 1760486400 on 20626892. Therefore, it implies a Short% of Shares Outstanding of 20122322 and a Short% of Float of 0.84.
Dividends & Splits
The forward annual dividend rate for JNJ is 5.14, which was 5.08 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.02447485. The stock’s 5-year Average Dividend Yield is 2.79. . The current Payout Ratio is 84.80% for JNJ, which recently paid a dividend on 2025-11-25 with an ex-dividend date of 2025-11-25. Stock splits for the company last occurred on 2001-06-13 when the company split stock in a 2:1 ratio.
Earnings Estimates
A comprehensive evaluation of Johnson & Johnson (JNJ) is underway, with the input of 18.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $2.76, with high estimates of $2.86 and low estimates of $2.65.
Analysts are recommending an EPS of between $10.96 and $10.77 for the fiscal current year, implying an average EPS of $10.86. EPS for the following year is $11.51, with 26.0 analysts recommending between $11.95 and $11.11.
Revenue Estimates
According to 16 analysts, . The current quarter’s revenue is expected to be $24.13B. It ranges from a high estimate of $24.48B to a low estimate of $23.88B. As of . The current estimate, Johnson & Johnson’s year-ago sales were $22.52BFor the next quarter, 16 analysts are estimating revenue of $23.05B. There is a high estimate of $23.5B for the next quarter, whereas the lowest estimate is $22.26B.
A total of 22 analysts have provided revenue estimates for JNJ’s current fiscal year. The highest revenue estimate was $94.05B, while the lowest revenue estimate was $93.42B, resulting in an average revenue estimate of $93.74B. In the same quarter a year ago, actual revenue was $88.82BBased on 24 analysts’ estimates, the company’s revenue will be $98.42B in the next fiscal year. The high estimate is $99.64B and the low estimate is $95.16B.